Tapewire

Nasdaq · USD

MYSZ

My Size, Inc.

Export transactions ↓
Tapewire entity
8556
SEC CIK
0001211805
Parsed reports
96

Last 12 months

Inside the activity.

6 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202540
Dec 202520
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
December 29, 2025 Filed Dec 30, 2025 10:05 UTC
Luzon RonenDirector · Chief Executive Officer
PurchaseCommon Stock 3,750 $0.78 $2,925.00
Disclosure

SEC source: 0001493152-25-029521 · ownership.xml · nonDerivative · entry 1

Luzon Ronen · CIK 0001686315 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 293,085

F1 · price: The reported price is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $0.77 to $0.79 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Read SEC document
December 15, 2025 Filed Dec 17, 2025 16:15 UTC GrantCommon Stock 15,000 $0.00 $0.00
Disclosure

SEC source: 0001493152-25-028139 · ownership.xml · nonDerivative · entry 1

Zimmerman Guy · CIK 0001879643 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,500

F1 · shares: Restricted shares granted under the My Size, Inc. 2017 Equity Incentive Plan.

F2 · shares: The restricted shares vest on December 31, 2025, subject to the Reporting Person's continued service to the Issuer as of such vesting date.

Read SEC document
December 15, 2025 Filed Dec 17, 2025 16:15 UTC
Elmaliah OrenChief Financial Officer
GrantCommon Stock 30,000 $0.00 $0.00
Disclosure

SEC source: 0001493152-25-028140 · ownership.xml · nonDerivative · entry 1

Elmaliah Oren · CIK 0001713701 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 32,500

F1 · shares: Restricted shares granted under the My Size, Inc. 2017 Equity Incentive Plan.

F2 · shares: The restricted shares vest in three equal annual installments, with 1/3 vesting on each of January 1, 2026, January 1, 2027 and January 1, 2028, subject to the Reporting Person's continued service to the Issuer as of each vesting date.

Read SEC document
December 15, 2025 Filed Dec 17, 2025 16:15 UTC
Pardo BillyCPO & COO
GrantCommon Stock 215,000 $0.00 $0.00
Disclosure

SEC source: 0001493152-25-028144 · ownership.xml · nonDerivative · entry 2

Pardo Billy · CIK 0001686858 · CPO & COO

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 289,335

F1 · shares: Restricted shares granted under the My Size, Inc. 2017 Equity Incentive Plan (the "Plan").

F4 · shares: 75,000 restricted shares vest in three equal annual installments, with 1/3 vesting on each of January 1, 2026, January 1, 2027 and January 1, 2028, subject to the Reporting Person's spouse continued service to the Issuer as of each vesting date.

F5 · shares: Up to 125,000 restricted shares vest upon and subject to achievement of certain profit and business targets as set forth in the restricted stock agreement, subject to the Reporting Person's spouse continued service to the Issuer as of each vesting date.

F6 · shares: 15,000 restricted shares vest on December 31, 2025, subject to the Reporting Person's spouse continued service to the Issuer as of such vesting date.

F7 · ownership.nature: Common stock beneficially owned by Reporting Person's Spouse (Director and Chief Executive Officer Ronen Luzon) under the Plan.

Read SEC document
December 15, 2025 Filed Dec 17, 2025 16:15 UTC
Pardo BillyCPO & COO
GrantCommon Stock 60,000 $0.00 $0.00
Disclosure

SEC source: 0001493152-25-028144 · ownership.xml · nonDerivative · entry 1

Pardo Billy · CIK 0001686858 · CPO & COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 79,750

F1 · shares: Restricted shares granted under the My Size, Inc. 2017 Equity Incentive Plan (the "Plan").

F2 · shares: 40,000 restricted shares vest in three equal annual installments, with 1/3 vesting on each of January 1, 2026, January 1, 2027 and January 1, 2028, subject to the Reporting Person's continued service to the Issuer as of each vesting date.

F3 · shares: Up to 20,000 restricted shares vest upon and subject to achievement of certain profit and business targets as set forth in the restricted stock agreement, subject to the Reporting Person's continued service to the Issuer as of each vesting date.

Read SEC document
December 15, 2025 Filed Dec 17, 2025 16:15 UTC
Luzon RonenDirector · Chief Executive Officer
GrantCommon Stock 60,000 $0.00 $0.00
Disclosure

SEC source: 0001493152-25-028147 · ownership.xml · nonDerivative · entry 2

Luzon Ronen · CIK 0001686315 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 79,750

F1 · shares: Restricted shares granted under the My Size, Inc. 2017 Equity Incentive Plan (the "Plan").

F5 · shares: 40,000 restricted shares vest in three equal annual installments, with 1/3 vesting on each of January 1, 2026, January 1, 2027 and January 1, 2028, subject to the Reporting Person's spouse continued service to the Issuer as of each vesting date.

F6 · shares: Up to 20,000 restricted shares vest upon and subject to achievement of certain profit and business targets as set forth in the restricted stock agreement, subject to the Reporting Person's spouse continued service to the Issuer as of each vesting date.

F7 · ownership.nature: Common stock beneficially owned by Reporting Perosn's Spouse (Chief Product Officer and Chief Operating Officer Billy Pardo) under the Plan.

Read SEC document
December 15, 2025 Filed Dec 17, 2025 16:15 UTC
Luzon RonenDirector · Chief Executive Officer
GrantCommon Stock 215,000 $0.00 $0.00
Disclosure

SEC source: 0001493152-25-028147 · ownership.xml · nonDerivative · entry 1

Luzon Ronen · CIK 0001686315 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 289,335

F1 · shares: Restricted shares granted under the My Size, Inc. 2017 Equity Incentive Plan (the "Plan").

F2 · shares: 75,000 restricted shares vest in three equal annual installments, with 1/3 vesting on each of January 1, 2026, January 1, 2027 and January 1, 2028, subject to the Reporting Person's continued service to the Issuer as of each vesting date.

F3 · shares: Up to 125,000 restricted shares vest upon and subject to achievement of certain profit and business targets as set forth in the restricted stock agreement, subject to the Reporting Person's continued service to the Issuer as of each vesting date.

F4 · shares: 15,000 restricted shares vest on December 31, 2025, subject to the Reporting Person's continued service to the Issuer as of such vesting date.

Read SEC document
December 15, 2025 Filed Dec 17, 2025 21:15 UTC GrantCommon Stock 15,000 $0.00 $0.00
Disclosure

SEC source: 0001493152-25-028141 · ownership.xml · nonDerivative · entry 1

Branitzky Oron · CIK 0001714993 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,500

F1 · shares: Restricted shares granted under the My Size, Inc. 2017 Equity Incentive Plan.

F2 · shares: The restricted shares vest on December 31, 2025, subject to the Reporting Person's continued service to the Issuer as of such vesting date.

Read SEC document
December 15, 2025 Filed Dec 17, 2025 21:15 UTC
Cembrero Saralegui BorjaChief Growth Officer
GrantCommon Stock 110,000 $0.00 $0.00
Disclosure

SEC source: 0001493152-25-028146 · ownership.xml · nonDerivative · entry 1

Cembrero Saralegui Borja · CIK 0002067690 · Chief Growth Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 117,965

F1 · shares: Restricted shares granted under the My Size, Inc. 2017 Equity Incentive Plan (the "Plan").

F2 · shares: 10,000 restricted shares vest upon grant date.

F3 · shares: 40,000 restricted shares vest in three equal annual installments, with 1/3 vesting on each of January 1, 2026, January 1, 2027 and January 1, 2028, subject to the Reporting Person's continued service to the Issuer as of each vesting date.

F4 · shares: Up to 60,000 restricted shares vest upon and subject to achievement of certain profit and business targets as set forth in the restricted stock agreement, subject to the Reporting Person's continued service to the Issuer as of each vesting date.

Read SEC document
December 15, 2025 Filed Dec 17, 2025 21:15 UTC
Golan RoyDirector
GrantCommon Stock 15,000 $0.00 $0.00
Disclosure

SEC source: 0001493152-25-028143 · ownership.xml · nonDerivative · entry 1

Golan Roy · CIK 0001999257 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,000

F1 · shares: Restricted shares granted under the My Size, Inc. 2017 Equity Incentive Plan.

F2 · shares: The restricted shares vest on December 31, 2025, subject to the Reporting Person's continued service to the Issuer as of such vesting date.

Read SEC document
December 15, 2025 Filed Dec 17, 2025 21:15 UTC
Kaufman ArikDirector
GrantCommon Stock 15,000 $0.00 $0.00
Disclosure

SEC source: 0001493152-25-028142 · ownership.xml · nonDerivative · entry 1

Kaufman Arik · CIK 0001713725 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,500

F1 · shares: Restricted shares granted under the My Size, Inc. 2017 Equity Incentive Plan.

F2 · shares: The restricted shares vest on December 31, 2025, subject to the Reporting Person's continued service to the Issuer as of such vesting date.

Read SEC document
December 01, 2025 Filed Dec 2, 2025 12:48 UTC
Luzon RonenDirector · Chief Executive Officer
PurchaseCommon Stock 2,600 $0.91 $2,353.00
Disclosure

SEC source: 0001493152-25-025691 · ownership.xml · nonDerivative · entry 1

Luzon Ronen · CIK 0001686315 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 74,335

F1 · price: The reported price is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $0.88 to $0.93 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Read SEC document
November 25, 2025 Filed Nov 26, 2025 11:05 UTC
Luzon RonenDirector · Chief Executive Officer
PurchaseCommon Stock 14,000 $0.90 $12,530.00
Disclosure

SEC source: 0001493152-25-025078 · ownership.xml · nonDerivative · entry 2

Luzon Ronen · CIK 0001686315 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 71,735

F2 · price: The reported price is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $0.83 to $0.96 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Read SEC document
November 24, 2025 Filed Nov 26, 2025 11:05 UTC
Luzon RonenDirector · Chief Executive Officer
PurchaseCommon Stock 235 $0.89 $207.98
Disclosure

SEC source: 0001493152-25-025078 · ownership.xml · nonDerivative · entry 1

Luzon Ronen · CIK 0001686315 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 57,735

F1 · price: The reported price is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $0.88 to $0.89 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Read SEC document
November 20, 2025 Filed Nov 21, 2025 08:55 UTC
Luzon RonenDirector · Chief Executive Officer
PurchaseCommon Stock 3,000 $0.77 $2,310.00
Disclosure

SEC source: 0001493152-25-024553 · ownership.xml · nonDerivative · entry 2

Luzon Ronen · CIK 0001686315 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 57,500

Read SEC document
November 20, 2025 Filed Nov 21, 2025 08:55 UTC
Luzon RonenDirector · Chief Executive Officer
PurchaseCommon Stock 10,500 $0.76 $7,980.00
Disclosure

SEC source: 0001493152-25-024553 · ownership.xml · nonDerivative · entry 1

Luzon Ronen · CIK 0001686315 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 54,500

Read SEC document
June 04, 2025 Filed Jun 6, 2025 16:10 UTC
Elmaliah OrenChief Financial Officer
GrantOption to purchase Common Stock (right to buy) · Derivative 150 Not disclosed Strike: $1.28 Not disclosed
Disclosure

SEC source: 0001641172-25-014032 · ownership.xml · derivative · entry 2

Elmaliah Oren · CIK 0001713701 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 150

Underlying: Common Stock, $.001 par value per share · 150 shares

Expires 2025-08-10

F2 · price: Effective June 4, 2025, the Board of Directors of the Company approved a unilateral option repricing, which resulted in the reduction of the exercise price to $1.28 per share, which is the closing price of the Company's common stock on June 4, 2025. All of the other terms of the option remained unchanged.

F1 · derivative.exercise_date: Option grant under the My Size, Inc. 2017 Equity Incentive Plan, all of which have vested.

Read SEC document
June 04, 2025 Filed Jun 6, 2025 16:10 UTC
Elmaliah OrenChief Financial Officer
Disposition to issuerOption to purchase Common Stock (right to buy) · Derivative 150 Not disclosed Strike: $8.72 Not disclosed
Disclosure

SEC source: 0001641172-25-014032 · ownership.xml · derivative · entry 1

Elmaliah Oren · CIK 0001713701 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock, $.001 par value per share · 150 shares

Expires 2025-08-10

F2 · price: Effective June 4, 2025, the Board of Directors of the Company approved a unilateral option repricing, which resulted in the reduction of the exercise price to $1.28 per share, which is the closing price of the Company's common stock on June 4, 2025. All of the other terms of the option remained unchanged.

F1 · derivative.exercise_date: Option grant under the My Size, Inc. 2017 Equity Incentive Plan, all of which have vested.

Read SEC document
June 04, 2025 Filed Jun 6, 2025 16:10 UTC
Pardo BillyCPO & COO
GrantOption to purchase Common Stock (right to buy) · Derivative 800 Not disclosed Strike: $1.28 Not disclosed
Disclosure

SEC source: 0001641172-25-014035 · ownership.xml · derivative · entry 4

Pardo Billy · CIK 0001686858 · CPO & COO

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 800

Underlying: Common Stock, $.001 par value per share · 800 shares

Expires 2025-08-10

F2 · price: Effective June 4, 2025, the Board of Directors of the Company approved a unilateral option repricing, which resulted in the reduction of the exercise price to $1.28 per share, which is the closing price of the Company's common stock on June 4, 2025. All of the other terms of the option remained unchanged.

F1 · derivative.exercise_date: Option grant under the My Size, Inc. 2017 Equity Incentive Plan, all of which have vested.

F3 · ownership.nature: Options acquired by Spouse (Chief Executive Officer Ronen Luzon).

Read SEC document
June 04, 2025 Filed Jun 6, 2025 16:10 UTC
Pardo BillyCPO & COO
Disposition to issuerOption to purchase Common Stock (right to buy) · Derivative 800 Not disclosed Strike: $8.72 Not disclosed
Disclosure

SEC source: 0001641172-25-014035 · ownership.xml · derivative · entry 3

Pardo Billy · CIK 0001686858 · CPO & COO

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 0

Underlying: Common Stock, $.001 par value per share · 800 shares

Expires 2025-08-10

F2 · price: Effective June 4, 2025, the Board of Directors of the Company approved a unilateral option repricing, which resulted in the reduction of the exercise price to $1.28 per share, which is the closing price of the Company's common stock on June 4, 2025. All of the other terms of the option remained unchanged.

F1 · derivative.exercise_date: Option grant under the My Size, Inc. 2017 Equity Incentive Plan, all of which have vested.

F3 · ownership.nature: Options acquired by Spouse (Chief Executive Officer Ronen Luzon).

Read SEC document
June 04, 2025 Filed Jun 6, 2025 16:10 UTC
Pardo BillyCPO & COO
GrantOption to purchase Common Stock (right to buy) · Derivative 650 Not disclosed Strike: $1.28 Not disclosed
Disclosure

SEC source: 0001641172-25-014035 · ownership.xml · derivative · entry 2

Pardo Billy · CIK 0001686858 · CPO & COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 650

Underlying: Common Stock, $.001 par value per share · 650 shares

Expires 2025-08-10

F2 · price: Effective June 4, 2025, the Board of Directors of the Company approved a unilateral option repricing, which resulted in the reduction of the exercise price to $1.28 per share, which is the closing price of the Company's common stock on June 4, 2025. All of the other terms of the option remained unchanged.

F1 · derivative.exercise_date: Option grant under the My Size, Inc. 2017 Equity Incentive Plan, all of which have vested.

Read SEC document
June 04, 2025 Filed Jun 6, 2025 16:10 UTC
Pardo BillyCPO & COO
Disposition to issuerOption to purchase Common Stock (right to buy) · Derivative 650 Not disclosed Strike: $8.72 Not disclosed
Disclosure

SEC source: 0001641172-25-014035 · ownership.xml · derivative · entry 1

Pardo Billy · CIK 0001686858 · CPO & COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock, $.001 par value per share · 650 shares

Expires 2025-08-10

F2 · price: Effective June 4, 2025, the Board of Directors of the Company approved a unilateral option repricing, which resulted in the reduction of the exercise price to $1.28 per share, which is the closing price of the Company's common stock on June 4, 2025. All of the other terms of the option remained unchanged.

F1 · derivative.exercise_date: Option grant under the My Size, Inc. 2017 Equity Incentive Plan, all of which have vested.

Read SEC document
June 04, 2025 Filed Jun 6, 2025 16:10 UTC
Luzon RonenDirector · Chief Executive Officer
GrantOption to purchase Common Stock (right to buy) · Derivative 650 Not disclosed Strike: $1.28 Not disclosed
Disclosure

SEC source: 0001641172-25-014034 · ownership.xml · derivative · entry 4

Luzon Ronen · CIK 0001686315 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · see footnote

Disclosed balance after: 650

Underlying: Common Stock, $.001 par value per share · 650 shares

Expires 2025-08-10

F2 · price: Effective June 4, 2025, the Board of Directors of the Company approved a unilateral option repricing, which resulted in the reduction of the exercise price to $1.28 per share, which is the closing price of the Company's common stock on June 4, 2025. All of the other terms of the option remained unchanged.

F1 · derivative.exercise_date: Option grant under the My Size, Inc. 2017 Equity Incentive Plan, all of which have vested.

F3 · ownership.nature: Options acquired by Spouse (Chief Product Officer and Chief Operating Officer Billy Pardo).

Read SEC document
June 04, 2025 Filed Jun 6, 2025 16:10 UTC
Luzon RonenDirector · Chief Executive Officer
Disposition to issuerOption to purchase Common Stock (right to buy) · Derivative 650 Not disclosed Strike: $8.72 Not disclosed
Disclosure

SEC source: 0001641172-25-014034 · ownership.xml · derivative · entry 3

Luzon Ronen · CIK 0001686315 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · see footnote

Disclosed balance after: 0

Underlying: Common Stock, $.001 par value per share · 650 shares

Expires 2025-08-10

F2 · price: Effective June 4, 2025, the Board of Directors of the Company approved a unilateral option repricing, which resulted in the reduction of the exercise price to $1.28 per share, which is the closing price of the Company's common stock on June 4, 2025. All of the other terms of the option remained unchanged.

F1 · derivative.exercise_date: Option grant under the My Size, Inc. 2017 Equity Incentive Plan, all of which have vested.

F3 · ownership.nature: Options acquired by Spouse (Chief Product Officer and Chief Operating Officer Billy Pardo).

Read SEC document
June 04, 2025 Filed Jun 6, 2025 16:10 UTC
Luzon RonenDirector · Chief Executive Officer
GrantOption to purchase Common Stock (right to buy) · Derivative 800 Not disclosed Strike: $1.28 Not disclosed
Disclosure

SEC source: 0001641172-25-014034 · ownership.xml · derivative · entry 2

Luzon Ronen · CIK 0001686315 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 800

Underlying: Common Stock, $.001 par value per share · 800 shares

Expires 2025-08-10

F2 · price: Effective June 4, 2025, the Board of Directors of the Company approved a unilateral option repricing, which resulted in the reduction of the exercise price to $1.28 per share, which is the closing price of the Company's common stock on June 4, 2025. All of the other terms of the option remained unchanged.

F1 · derivative.exercise_date: Option grant under the My Size, Inc. 2017 Equity Incentive Plan, all of which have vested.

Read SEC document
June 04, 2025 Filed Jun 6, 2025 16:10 UTC
Luzon RonenDirector · Chief Executive Officer
Disposition to issuerOption to purchase Common Stock (right to buy) · Derivative 800 Not disclosed Strike: $8.72 Not disclosed
Disclosure

SEC source: 0001641172-25-014034 · ownership.xml · derivative · entry 1

Luzon Ronen · CIK 0001686315 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock, $.001 par value per share · 800 shares

Expires 2025-08-10

F2 · price: Effective June 4, 2025, the Board of Directors of the Company approved a unilateral option repricing, which resulted in the reduction of the exercise price to $1.28 per share, which is the closing price of the Company's common stock on June 4, 2025. All of the other terms of the option remained unchanged.

F1 · derivative.exercise_date: Option grant under the My Size, Inc. 2017 Equity Incentive Plan, all of which have vested.

Read SEC document
June 04, 2025 Filed Jun 6, 2025 20:10 UTC GrantOption to purchase Common Stock (right to buy) · Derivative 150 Not disclosed Strike: $1.28 Not disclosed
Disclosure

SEC source: 0001641172-25-014030 · ownership.xml · derivative · entry 2

Branitzky Oron · CIK 0001714993 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 150

Underlying: Common Stock, $.001 par value per share · 150 shares

Expires 2025-08-10

F2 · price: Effective June 4, 2025, the Board of Directors of the Company approved a unilateral option repricing, which resulted in the reduction of the exercise price to $1.28 per share, which is the closing price of the Company's common stock on June 4, 2025. All of the other terms of the option remained unchanged.

F1 · derivative.exercise_date: Option grant under the My Size, Inc. 2017 Equity Incentive Plan, all of which have vested.

Read SEC document
June 04, 2025 Filed Jun 6, 2025 20:10 UTC Disposition to issuerOption to purchase Common Stock (right to buy) · Derivative 150 Not disclosed Strike: $8.72 Not disclosed
Disclosure

SEC source: 0001641172-25-014030 · ownership.xml · derivative · entry 1

Branitzky Oron · CIK 0001714993 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock, $.001 par value per share · 150 shares

Expires 2025-08-10

F2 · price: Effective June 4, 2025, the Board of Directors of the Company approved a unilateral option repricing, which resulted in the reduction of the exercise price to $1.28 per share, which is the closing price of the Company's common stock on June 4, 2025. All of the other terms of the option remained unchanged.

F1 · derivative.exercise_date: Option grant under the My Size, Inc. 2017 Equity Incentive Plan, all of which have vested.

Read SEC document
June 04, 2025 Filed Jun 6, 2025 20:10 UTC
Cembrero Saralegui BorjaChief Growth Officer
GrantOption to purchase Common Stock (right to buy) · Derivative 2,500 Not disclosed Strike: $1.28 Not disclosed
Disclosure

SEC source: 0001641172-25-014031 · ownership.xml · derivative · entry 4

Cembrero Saralegui Borja · CIK 0002067690 · Chief Growth Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,500

Underlying: Common Stock, $.001 par value per share · 2,500 shares

Expires 2029-02-14

F3 · price: Effective June 4, 2025, the Board of Directors of the Company approved a unilateral option repricing, which resulted in the reduction of the exercise price to $1.28 per share, which is the closing price of the Company's common stock on June 4, 2025. All of the other terms of the option remained unchanged.

F2 · derivative.exercise_date: The options were granted under the My Size, Inc. 2017 Equity Incentive Plan and vest and become exercisable in three equal installments, with 1/3 vesting on each of February 14, 2025, February 14, 2026 and February 14, 2027, subject to the Reporting Person's continued service.

Read SEC document
June 04, 2025 Filed Jun 6, 2025 20:10 UTC
Cembrero Saralegui BorjaChief Growth Officer
Disposition to issuerOption to purchase Common Stock (right to buy) · Derivative 2,500 Not disclosed Strike: $3.83 Not disclosed
Disclosure

SEC source: 0001641172-25-014031 · ownership.xml · derivative · entry 3

Cembrero Saralegui Borja · CIK 0002067690 · Chief Growth Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock, $.001 par value per share · 2,500 shares

Expires 2029-02-14

F3 · price: Effective June 4, 2025, the Board of Directors of the Company approved a unilateral option repricing, which resulted in the reduction of the exercise price to $1.28 per share, which is the closing price of the Company's common stock on June 4, 2025. All of the other terms of the option remained unchanged.

F2 · derivative.exercise_date: The options were granted under the My Size, Inc. 2017 Equity Incentive Plan and vest and become exercisable in three equal installments, with 1/3 vesting on each of February 14, 2025, February 14, 2026 and February 14, 2027, subject to the Reporting Person's continued service.

Read SEC document
June 04, 2025 Filed Jun 6, 2025 20:10 UTC
Cembrero Saralegui BorjaChief Growth Officer
GrantOption to purchase Common Stock (right to buy) · Derivative 1,688 Not disclosed Strike: $1.28 Not disclosed
Disclosure

SEC source: 0001641172-25-014031 · ownership.xml · derivative · entry 2

Cembrero Saralegui Borja · CIK 0002067690 · Chief Growth Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,688

Underlying: Common Stock, $.001 par value per share · 1,688 shares

Expires 2028-07-13

F3 · price: Effective June 4, 2025, the Board of Directors of the Company approved a unilateral option repricing, which resulted in the reduction of the exercise price to $1.28 per share, which is the closing price of the Company's common stock on June 4, 2025. All of the other terms of the option remained unchanged.

F1 · derivative.exercise_date: The options were granted under the My Size, Inc. 2017 Equity Incentive Plan and vest and become exercisable in three equal installments, with 1/3 vesting on each of July 13, 2024, July 13, 2025 and July 13, 2026, subject to the Reporting Person's continued service.

Read SEC document
June 04, 2025 Filed Jun 6, 2025 20:10 UTC
Cembrero Saralegui BorjaChief Growth Officer
Disposition to issuerOption to purchase Common Stock (right to buy) · Derivative 1,688 Not disclosed Strike: $8.72 Not disclosed
Disclosure

SEC source: 0001641172-25-014031 · ownership.xml · derivative · entry 1

Cembrero Saralegui Borja · CIK 0002067690 · Chief Growth Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock, $.001 par value per share · 1,688 shares

Expires 2028-07-13

F3 · price: Effective June 4, 2025, the Board of Directors of the Company approved a unilateral option repricing, which resulted in the reduction of the exercise price to $1.28 per share, which is the closing price of the Company's common stock on June 4, 2025. All of the other terms of the option remained unchanged.

F1 · derivative.exercise_date: The options were granted under the My Size, Inc. 2017 Equity Incentive Plan and vest and become exercisable in three equal installments, with 1/3 vesting on each of July 13, 2024, July 13, 2025 and July 13, 2026, subject to the Reporting Person's continued service.

Read SEC document
June 04, 2025 Filed Jun 6, 2025 20:10 UTC
Kaufman ArikDirector
GrantOption to purchase Common Stock (right to buy) · Derivative 150 Not disclosed Strike: $1.28 Not disclosed
Disclosure

SEC source: 0001641172-25-014033 · ownership.xml · derivative · entry 2

Kaufman Arik · CIK 0001713725 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 150

Underlying: Common Stock, $.001 par value per share · 150 shares

Expires 2025-08-10

F2 · price: Effective June 4, 2025, the Board of Directors of the Company approved a unilateral option repricing, which resulted in the reduction of the exercise price to $1.28 per share, which is the closing price of the Company's common stock on June 4, 2025. All of the other terms of the option remained unchanged.

F1 · derivative.exercise_date: Option grant under the My Size, Inc. 2017 Equity Incentive Plan, all of which have vested.

Read SEC document
June 04, 2025 Filed Jun 6, 2025 20:10 UTC
Kaufman ArikDirector
Disposition to issuerOption to purchase Common Stock (right to buy) · Derivative 150 Not disclosed Strike: $8.72 Not disclosed
Disclosure

SEC source: 0001641172-25-014033 · ownership.xml · derivative · entry 1

Kaufman Arik · CIK 0001713725 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock, $.001 par value per share · 150 shares

Expires 2025-08-10

F2 · price: Effective June 4, 2025, the Board of Directors of the Company approved a unilateral option repricing, which resulted in the reduction of the exercise price to $1.28 per share, which is the closing price of the Company's common stock on June 4, 2025. All of the other terms of the option remained unchanged.

F1 · derivative.exercise_date: Option grant under the My Size, Inc. 2017 Equity Incentive Plan, all of which have vested.

Read SEC document
December 30, 2024 Filed Jan 2, 2025 16:15 UTC
Pardo BillyCPO & COO
SaleCommon Stock 2,000 $5.40 $10,800.00
Disclosure

SEC source: 0001493152-25-000061 · ownership.xml · nonDerivative · entry 4

Pardo Billy · CIK 0001686858 · CPO & COO

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 44,000

F1 · ownership.nature: Common stock beneficially owned by Spouse (Chief Executive Officer Ronen Luzon) under the My Size, Inc. 2017 Equity Incentive Plan.

Read SEC document
December 30, 2024 Filed Jan 2, 2025 16:15 UTC
Pardo BillyCPO & COO
SaleCommon Stock 2,000 $5.10 $10,200.00
Disclosure

SEC source: 0001493152-25-000061 · ownership.xml · nonDerivative · entry 3

Pardo Billy · CIK 0001686858 · CPO & COO

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 46,000

F1 · ownership.nature: Common stock beneficially owned by Spouse (Chief Executive Officer Ronen Luzon) under the My Size, Inc. 2017 Equity Incentive Plan.

Read SEC document
December 30, 2024 Filed Jan 2, 2025 16:15 UTC
Pardo BillyCPO & COO
SaleCommon Stock 2,000 $5.12 $10,240.00
Disclosure

SEC source: 0001493152-25-000061 · ownership.xml · nonDerivative · entry 2

Pardo Billy · CIK 0001686858 · CPO & COO

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 48,000

F1 · ownership.nature: Common stock beneficially owned by Spouse (Chief Executive Officer Ronen Luzon) under the My Size, Inc. 2017 Equity Incentive Plan.

Read SEC document
December 30, 2024 Filed Jan 2, 2025 16:15 UTC
Pardo BillyCPO & COO
SaleCommon Stock 2,000 $5.10 $10,200.00
Disclosure

SEC source: 0001493152-25-000061 · ownership.xml · nonDerivative · entry 1

Pardo Billy · CIK 0001686858 · CPO & COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,750

Read SEC document
December 30, 2024 Filed Jan 2, 2025 16:15 UTC
Kles OrChief Financial Officer
SaleCommon Stock 2,000 $5.40 $10,800.00
Disclosure

SEC source: 0001493152-25-000062 · ownership.xml · nonDerivative · entry 1

Kles Or · CIK 0001686316 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,750

Read SEC document
December 30, 2024 Filed Jan 2, 2025 16:15 UTC
Luzon RonenDirector · Chief Executive Officer
SaleCommon Stock 2,000 $5.10 $10,200.00
Disclosure

SEC source: 0001493152-25-000064 · ownership.xml · nonDerivative · entry 4

Luzon Ronen · CIK 0001686315 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 19,750

F1 · ownership.nature: Common stock beneficially owned by Spouse (Chief Product Officer and Chief Operating Officer Billy Pardo) under the My Size, Inc. 2017 Equity Incentive Plan.

Read SEC document
December 30, 2024 Filed Jan 2, 2025 16:15 UTC
Luzon RonenDirector · Chief Executive Officer
SaleCommon Stock 2,000 $5.40 $10,800.00
Disclosure

SEC source: 0001493152-25-000064 · ownership.xml · nonDerivative · entry 3

Luzon Ronen · CIK 0001686315 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 44,000

Read SEC document
December 30, 2024 Filed Jan 2, 2025 16:15 UTC
Luzon RonenDirector · Chief Executive Officer
SaleCommon Stock 2,000 $5.10 $10,200.00
Disclosure

SEC source: 0001493152-25-000064 · ownership.xml · nonDerivative · entry 2

Luzon Ronen · CIK 0001686315 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 46,000

Read SEC document
December 30, 2024 Filed Jan 2, 2025 16:15 UTC
Luzon RonenDirector · Chief Executive Officer
SaleCommon Stock 2,000 $5.12 $10,240.00
Disclosure

SEC source: 0001493152-25-000064 · ownership.xml · nonDerivative · entry 1

Luzon Ronen · CIK 0001686315 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 48,000

Read SEC document
December 30, 2024 Filed Feb 12, 2025 16:34 UTC SaleCommon stock 100 $5.48 $548.00
Disclosure

SEC source: 0001214659-25-002494 · marketforms-68044.xml · nonDerivative · entry 2

AVATAR SECURITIES, LLC · CIK 0001438956 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 31,086

Read SEC document
December 30, 2024 Filed Feb 12, 2025 16:34 UTC SaleCommon stock 120,524 $4.85 $584,541.40
Disclosure

SEC source: 0001214659-25-002494 · marketforms-68044.xml · nonDerivative · entry 1

AVATAR SECURITIES, LLC · CIK 0001438956 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 31,186

F1 · price: Weighted average price. These shares were sold in multiple transactions at prices ranging from $4.47 to $5.42 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

Read SEC document
February 14, 2024 Filed Feb 16, 2024 16:20 UTC GrantCommon Stock 20,000 $0.00 $0.00
Disclosure

SEC source: 0001493152-24-007021 · ownership.xml · nonDerivative · entry 1

Zimmerman Guy · CIK 0001879643 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,000

F1 · shares: Restricted stock units granted under the My Size, Inc. 2017 Equity Incentive Plan, which vest on January 1, 2025.

Read SEC document
February 14, 2024 Filed Feb 16, 2024 16:20 UTC GrantCommon Stock 20,000 $0.00 $0.00
Disclosure

SEC source: 0001493152-24-007017 · ownership.xml · nonDerivative · entry 1

Elmaliah Oren · CIK 0001713701 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,000

F1 · shares: Restricted stock units granted under the My Size, Inc. 2017 Equity Incentive Plan, which vest on January 1, 2025.

Read SEC document
February 14, 2024 Filed Feb 16, 2024 16:20 UTC
Pardo BillyCPO & COO
GrantCommon Stock 300,000 $0.00 $0.00
Disclosure

SEC source: 0001493152-24-007019 · ownership.xml · nonDerivative · entry 2

Pardo Billy · CIK 0001686858 · CPO & COO

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 400,000

F1 · shares: Restricted stock granted under the My Size, Inc. 2017 Equity Incentive Plan, which vests in three equal annual installments, with 1/3 vesting on each of January 1, 2025, January 1, 2026 and January 1, 2027, subject to the Reporting Person continuously providing services to the Issuer as an employee through such vesting date.

F2 · ownership.nature: Common stock beneficially owned by Spouse (Chief Executive Officer Ronen Luzon) under the My Size, Inc. 2017 Equity Incentive Plan.

Read SEC document
February 14, 2024 Filed Feb 16, 2024 16:20 UTC
Pardo BillyCPO & COO
GrantCommon Stock 150,000 $0.00 $0.00
Disclosure

SEC source: 0001493152-24-007019 · ownership.xml · nonDerivative · entry 1

Pardo Billy · CIK 0001686858 · CPO & COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 174,000

F1 · shares: Restricted stock granted under the My Size, Inc. 2017 Equity Incentive Plan, which vests in three equal annual installments, with 1/3 vesting on each of January 1, 2025, January 1, 2026 and January 1, 2027, subject to the Reporting Person continuously providing services to the Issuer as an employee through such vesting date.

Read SEC document
February 14, 2024 Filed Feb 16, 2024 16:20 UTC
Kles OrChief Financial Officer
GrantCommon Stock 150,000 $0.00 $0.00
Disclosure

SEC source: 0001493152-24-007015 · ownership.xml · nonDerivative · entry 1

Kles Or · CIK 0001686316 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 174,000

F1 · shares: Restricted stock granted under the My Size, Inc. 2017 Equity Incentive Plan, which vests in three equal annual installments, with 1/3 vesting on each of January 1, 2025, January 1, 2026 and January 1, 2027, subject to the Reporting Person continuously providing services to the Issuer as an employee through such vesting date.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.